The use of adenoviral vectors in gene therapy and vaccine approaches
Abstract Adenovirus was first identified in the 1950s and since then this pathogenic group of viruses has been explored and transformed into a genetic transfer vehicle. Modification or deletion of few genes are necessary to transform it into a conditionally or non-replicative vector, creating a vers...
Үндсэн зохиолчид: | Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale, Rodrigo Esaki Tamura |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
Sociedade Brasileira de Genética
2022-10-01
|
Цуврал: | Genetics and Molecular Biology |
Нөхцлүүд: | |
Онлайн хандалт: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572022000400108&tlng=en |
Ижил төстэй зүйлс
-
Development of novel vaccine vectors: Chimpanzee adenoviral vectors
-н: Jingao Guo, зэрэг
Хэвлэсэн: (2018-07-01) -
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
-н: Lynda Coughlan
Хэвлэсэн: (2020-05-01) -
Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
-н: Luca Scarsella, зэрэг
Хэвлэсэн: (2024-02-01) -
Improving adenoviral vectors and strategies for prostate cancer gene therapy
-н: Rodrigo Esaki Tamura, зэрэг
Хэвлэсэн: (2018-08-01) -
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
-н: L. V. Cherenova, зэрэг
Хэвлэсэн: (2017-08-01)